Home » Posts tagged with » India
India-based Piramal Pharma secures $490m investment from Carlyle Group

India-based Piramal Pharma secures $490m investment from Carlyle Group

The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private equity firm will carry out the acquisition through CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, which is an […]

Glenmark Pharmaceuticals launches FabiFlu for COVID-19 treatment in India

Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm’s antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in patients with mild to moderate symptoms. The Indian pharma company has been granted manufacturing and marketing approval from the Drug Controller General of India (DCGI), a department of the Central […]

Continue reading …
Apollo Hospitals to use AI platform from Zebra Med for COVID-19 detection

Zebra Medical Vision (Zebra-Med), an Israel-based deep-learning medical imaging analytics company, said that its software will be deployed by India’s Apollo Hospitals Group to help its doctors in efficient and accurate diagnoses of COVID-19, by leveraging the former’s0 AI1 platform. The duo entered into a collaboration in March 2019 for deploying Zebra Medical Vision’s artificial […]

Continue reading …
Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Mahad API plant acquisition : Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has completed the acquisition of an API manufacturing facility in Mahad in Maharashtra, India. The company’s subsidiary Olon India will initiate all the activities the next April 1st as per the strategy of Olon after an intensive transition period that […]

Continue reading …
Lupin out-licenses MALT1 inhibitor program to AbbVie in $977m deal

Indian pharma company Lupin has out-licensed its MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program to US biopharma company AbbVie in a deal potentially worth around $977 million. Lupin and AbbVie have forged a partnership in this regard which gives the US biopharma company the exclusive global rights to develop and commercialize the […]

Continue reading …
MedGenome says cancer vaccine approach can help in Lynch Syndrome treatment

MedGenome, an Indian genomics research and diagnostics startup, in a recent study has found out that using a cancer vaccine approach can be applied in Lynch Syndrome treatment. The study conducted by MedGenome examined the feasibility of a personalized cancer vaccine approach by detecting potential immunogenic tumor specific alterations. Lynch Syndrome or hereditary non-polyposis colorectal […]

Continue reading …
Sandoz US to sell dermatology and oral solids businesses to Aurobindo

Pharma acquisition news : Sandoz US, a subsidiary of Swiss pharma company Novartis, has agreed to sell its dermatology and oral solids businesses to Indian pharma company Aurobindo Pharma in a deal that could fetch it up to $1 billion. As per the terms of the deal, the Indian pharma company through its subsidiary Aurobindo […]

Continue reading …
Italian CDMO Olon acquires API manufacturing plant in India

Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has acquired a generics chemical operations API manufacturing plant in Mahad in the Indian state of Maharashtra. According to Olan CEO Paolo Tubertini, the acquisition of AP manufacturing facility in India will give the company scope to speed up growth by adding new CDMO projects […]

Continue reading …
Cinchona – Chemical Constituents and Uses

Biological Source of Cinchona: Other names of Cinchona Bark: Cinchona is a dried bark obtained from the cultivated trees of Cinchona calisaya, Cinchona ledgeriana, Cinchona officinalis, Cinchona succirubra of the family Rubiaceae. Cinchona is called as Jesuit’s bark as this bark was identified and used by the Jesuits for its anti-pyretic property. As it was […]

Continue reading …